Biotech Values

[dewophile]

This would of course benefit PFE and MRNA too

MRNA is going to have a tough go in a shared decision making model w this efficacy update (which may not be fair since severity of dx is different between seasons but still it is what it is):

https://investors.modernatx.com/Statements--Perspectives/Statements--Perspectives-Details/2024/Statement-on-RSVVW-Abstract-on-mRNA-1345-2024-Rk2gVDGnqc/default.aspx

bullish for GSK and PFE now